Research has suggested that examination of pSer308 GATA3 expression in breast cancer patients could be predictive of GATA3 loss, enabling stratification of GATA3 positive tumours, as those predicted to lose GATA3 expression would be expected to display a poorer prognosis. Here, GATA3 is linked to breast carcinoma.